Archive: 2025/12 - Page 3

Monitoring Your Health After Switching to Generics

Monitoring Your Health After Switching to Generics

Switching to generic medications is safe for most people, but monitoring your health is crucial - especially if you're on drugs with narrow therapeutic indices like thyroid meds, blood thinners, or seizure drugs. Track symptoms, lab results, and NDC numbers after the switch.

Biosimilar Approval: How FDA Reviews Biologic Alternatives in 2025

Biosimilar Approval: How FDA Reviews Biologic Alternatives in 2025

The FDA's 2025 update to biosimilar approval rules removes unnecessary clinical trials, making cheaper biologic alternatives faster and easier to bring to market. Learn how biosimilars are reviewed, why they're different from generics, and what this means for patients.